Výsledky vyhledávání - "Véronique Parquet"

Synergy of mefloquine activity with atorvastatin, but not chloroquine and monodesethylamodiaquine, and association with the pfmdr1 gene

Autor: Bruno Pradines, Véronique Parquet, Christophe Rogier, Sébastien Briolant, Maud Henry, Marine Gil, Nathalie Wurtz, Rémy Amalvict, Lionel Almeras, Eric Baret

Publikováno v: Journal of Antimicrobial Chemotherapy. 65:1387-1394

OBJECTIVES The aim of the study was to assess the in vitro potentiating effects of atorvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, in combination with mefloquine, chloroquine or monodesethylamodiaquine against Pla

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b0f03dbfe6b04bc67383c0be7d69d4f
https://doi.org/10.1093/jac/dkq173

Zobrazit plný text záznamu

Atorvastatin Is a Promising Partner for Antimalarial Drugs in Treatment of Plasmodium falciparum Malaria

Autor: Eric Baret, Bruno Pradines, Marylin Torrentino-Madamet, Christophe Rogier, Thierry Fusai, Véronique Parquet, Maud Henry, Lionel Almeras, Sébastien Briolant, Rémy Amalvict

Publikováno v: Antimicrobial Agents and Chemotherapy. 53:2248-2252

During the past 20 years, many strains of Plasmodium falciparum have become resistant to chloroquine and other antimalarial drugs (20). This has prompted a search for an effective alternative antimalarial drug with minimal side effects. The emergence

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6f1c0bc434fd05ffc3a338f0cdca001
https://doi.org/10.1128/aac.01462-08

Zobrazit plný text záznamu

Atorvastatin as a potential anti-malarial drug: in vitro synergy in combinational therapy with quinine against Plasmodium falciparum

Autor: Marine Gil, Nathalie Wurtz, Bruno Pradines, Jérôme Dormoi, Eric Baret, Maud Henry, Véronique Parquet, Rémy Amalvict, Sébastien Briolant, Christophe Rogier

Publikováno v: Malaria Journal, Vol 9, Iss 1, p 139 (2010)
Malaria Journal

Background Quinine (QN) remains the first line anti-malarial drug for the treatment of complicated malaria in Europe and Africa. The emergence of QN resistance has been documented. QN resistance is not yet a significant problem, but there is an urgen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::854c9aec06f20884c4096c70f59427c2
http://www.malariajournal.com/content/9/1/139

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání